Immunoblotting confirmed this finding and further supported our hypothesis that knocking out Akt2 in RPE attenuates the diabetes-induced retinal fibrosis process by demonstrating that other fibrosis markers including collagen IV, CTGF, and fibronectin showed the similar pattern in the RPE (Fig. 6B–F). The gene discussed is AKT2; the disease is diabetes mellitus.